Sonuç Sayfası 10 için Sektör: Sağlık Hizmetleri Endüstri: Biyoteknoloji Borsası - Teklifler ve Fiyatlar
Fiyatlar, Piyasa Değerleri, PE ve EPS oranları ile tüm Hisse ve Net Varlıkların Listesi
Tüm ülkeler
- {{country.name}}
- Tüm ülkeler
- Amerika Birleşik Devletleri (646)
- Avustralya (45)
- Avusturya (11)
- Belçika (7)
- Brezilya (13)
- Kanada (49)
- Çin (89)
- Danimarka (6)
- Finlandiya (3)
- Fransa (26)
- Almanya (443)
- Hong Kong (45)
- Hindistan (19)
- İsrail (13)
- İtalya (3)
- Japonya (37)
- Meksika (26)
- Hollanda (3)
- Yeni Zelanda (1)
- Norveç (10)
- Polonya (8)
- Rusya (1)
- Güney Kore (79)
- ispanya (3)
- İsveç (58)
- İsviçre (10)
- Tayvan (59)
- Tayland (2)
- Türkiye (1)
- Birleşik Krallık (25)
Tüm borsalar
- {{item.name}}
- Tüm borsalar
- Amsterdam (3)
- Aquis AQSE (1)
- ASX (45)
- Brussels (7)
- BSE (12)
- Canadian Sec (22)
- Cboe CA (3)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (388)
- Hamburg (1)
- Helsinki (3)
- HKSE (45)
- IOB (24)
- Istanbul (1)
- KOSDAQ (69)
- KSE (10)
- MCE (3)
- MCX (1)
- Mexico (26)
- Milan (3)
- Munich (17)
- NSE (7)
- NYSE (5)
- NYSE American (14)
- NZSE (1)
- Oslo (10)
- OTC Markets EXMKT (40)
- OTC Markets OTCPK (107)
- OTC Markets OTCQB (30)
- OTC Markets OTCQX (5)
- Paris (26)
- São Paulo (13)
- Shanghai (46)
- Shenzhen (43)
- Stockholm (58)
- Stuttgart (21)
- Swiss (10)
- Taipei Exchange (53)
- Taiwan (6)
- Tech Market Large (153)
- Tech Market Middle (83)
- Tech Market Small (209)
- Tel Aviv (13)
- Thailand (2)
- Tokyo (37)
- Toronto (8)
- TSXV (16)
- Vienna (11)
- Warsaw (8)
- XETRA (15)
Sağlık Hizmetleri (1741)
- {{item.name}}
- Tüm sektörler
- Sağlık Hizmetleri (1741)
Biyoteknoloji (1741)
- {{item.name}}
- Tüm Sektörler
- Biyoteknoloji (1741)
- İlaç Üreticileri-Genel (1)
- İlaç Üreticileri-Özel ve Genel (77)
- Sağlık Hizmeti Planları (45)
- Tıbbi Bakım Tesisleri (434)
- Farmasötik Perakendeciler (103)
- Sağlık Bilgileri Hizmetleri (259)
- Tıbbi Cihazlar (737)
- Tıbbi Ekipmanlar ve Malzemeler (429)
- Teşhis ve Araştırma (337)
- Medikal Ürün Dağıtımı (148)
Market Heatmap
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK | Tahmin |
|---|
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK | Tahmin | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
Alnylam Pharmaceuticals, Inc.
A1LN34.SA
BR
|
R$80.96 16.41 USD |
-1.84
|
R$216.18B 43.82B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$216.18B 43.82B USD | 78.60 | R$1.03 0.21 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.F
DE
|
€273.00 315.13 USD |
0
|
€36.45B 42.07B USD | €10.00 11.54 USD | €271.60 313.52 USD | €275.00 317.44 USD | €36.45B 42.07B USD | 78.00 | €3.50 4.04 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.DE
DE
|
€272.30 314.33 USD |
-0.44
|
€36.36B 41.97B USD | €2.00 2.31 USD | €272.30 314.33 USD | €272.30 314.33 USD | €36.36B 41.97B USD | 77.79 | €3.50 4.04 USD | ||
Revolution Medicines, Inc.
42Z.F
DE
|
€170.00 196.24 USD |
0
|
€36.14B 41.72B USD | €160.00 184.69 USD | €168.75 194.79 USD | €170.00 196.24 USD | €36.14B 41.72B USD | 0 | -€6.25 -7.2 USD | ||
CSL
CMXHF
US
|
$86.80 — |
+4.35
|
$41.57B — | $200.00 — | $77.86 — | $77.89 — | $41.57B — | 14.06 | $6.17 — | ||
CSL Limited
CSJ.F
DE
|
€74.50 86 USD |
0
|
€35.68B 41.19B USD | €100.00 115.43 USD | €73.98 85.4 USD | €75.21 86.82 USD | €35.68B 41.19B USD | 13.74 | €5.42 6.26 USD | ||
CSL Limited
CSJA.F
DE
|
€17.60 20.32 USD |
0
|
€33.72B 38.92B USD | €100.00 115.43 USD | €17.60 20.32 USD | €17.60 20.32 USD | €33.72B 38.92B USD | 13.03 | €1.35 1.56 USD | ||
Royalty Pharma plc
RPD.MU
DE
|
€50.74 58.57 USD |
+1.4
|
€29.22B 33.73B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €29.22B 33.73B USD | 30.38 | €1.67 1.93 USD | ||
Royalty Pharma plc
RPD.F
DE
|
€50.60 58.41 USD |
0
|
€29.14B 33.63B USD | €40.00 46.17 USD | €49.08 56.65 USD | €52.93 61.1 USD | €29.14B 33.63B USD | 30.29 | €1.67 1.93 USD | ||
Moderna, Inc.
MRNA.VI
AT
|
€73.41 84.74 USD |
+3.73
|
€29.13B 33.62B USD | €4.96K 5.73K USD | €67.40 77.8 USD | €73.41 84.74 USD | €29.13B 33.62B USD | 0 | -€7.15 -8.2 USD | ||
Moderna, Inc.
MRNA.MX
MX
|
MX$1,425.33 84.4 USD |
+2.95
|
MX$565.55B 33.49B USD | MX$5.65K 334.55 USD | MX$1,380.00 81.71 USD | MX$1,451.38 85.94 USD | MX$565.55B 33.49B USD | 0 | -MX$146.80 -8.6 USD | ||
Moderna, Inc.
0QF.F
DE
|
€72.27 83.42 USD |
0
|
€28.68B 33.1B USD | €681.00 786.1 USD | €67.27 77.65 USD | €72.27 83.42 USD | €28.68B 33.1B USD | 0 | -€7.15 -8.2 USD | ||
Moderna, Inc.
0QF.MU
DE
|
€70.26 81.1 USD |
+0.34
|
€27.88B 32.18B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €27.88B 32.18B USD | 0 | -€7.15 -8.2 USD | ||
BeOne Medicines AG
49BA.F
DE
|
€268.00 309.36 USD |
0
|
€27.81B 32.1B USD | €60.00 69.26 USD | €268.00 309.36 USD | €276.00 318.6 USD | €27.81B 32.1B USD | 68.89 | €3.89 4.49 USD | ||
Celltrion, Inc.
068270.KS
KR
|
₩176,900 133.53 USD |
+0.57
|
₩41T 30.62B USD | ₩433K 326.54 USD | ₩172,700 130.36 USD | ₩178,500 134.74 USD | ₩41T 30.62B USD | 0 | ₩0 0 USD | ||
Royalty Pharma plc
RPRXN.MX
MX
|
MX$775.06 45.89 USD |
0
|
MX$446.30B 26.43B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$446.30B 26.43B USD | 23.69 | MX$32.71 1.94 USD | ||
BioNTech SE
0A3M.IL
GB
|
$95.25 — |
-1.55
|
$26.20B — | $0.00 — | $0.00 — | $0.00 — | $26.20B — | 5.29 | $18.00 — | ||
Roivant Sciences Ltd.
87S.F
DE
|
€30.74 35.48 USD |
0
|
€22.11B 25.52B USD | €350.00 404.02 USD | €30.37 35.06 USD | €30.74 35.48 USD | €22.11B 25.52B USD | 0 | -€0.47 -0.5 USD | ||
BioNTech SE
B1NT34.SA
BR
|
R$30.36 6.15 USD |
-2.32
|
R$124.07B 25.15B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$124.07B 25.15B USD | 0 | -R$1.87 -0.3 USD | ||
Insmed Incorporated
IM8N.F
DE
|
€98.73 113.97 USD |
0
|
€21.40B 24.7B USD | €290.00 334.76 USD | €98.73 113.97 USD | €99.38 114.72 USD | €21.40B 24.7B USD | 0 | -€5.05 -5.8 USD | ||
BioNTech SE
22UA.F
DE
|
€83.45 96.33 USD |
0
|
€21.10B 24.36B USD | €1.01K 1.17K USD | €82.55 95.29 USD | €84.00 96.96 USD | €21.10B 24.36B USD | 0 | -€5.07 -5.8 USD | ||
Insmed Incorporated
IM8N.SG
DE
|
€97.29 112.31 USD |
-0.21
|
€21.09B 24.34B USD | €0.00 0 USD | €97.28 112.29 USD | €97.29 112.31 USD | €21.09B 24.34B USD | 0 | -€5.05 -5.8 USD | ||
BioNTech SE
BNTX.VI
AT
|
€83.35 96.21 USD |
-1.59
|
€21.08B 24.33B USD | €3.88K 4.48K USD | €82.25 94.94 USD | €84.20 97.19 USD | €21.08B 24.33B USD | 0 | -€5.07 -5.8 USD | ||
Incyte Corporation
I1NC34.SA
BR
|
R$296.96 60.19 USD |
0
|
R$118.65B 24.05B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$118.65B 24.05B USD | 16.18 | R$18.35 3.72 USD | ||
Incyte Corporation
ICY.F
DE
|
€103.60 119.59 USD |
0
|
€20.70B 23.89B USD | €165.00 190.47 USD | €103.40 119.36 USD | €103.60 119.59 USD | €20.70B 23.89B USD | 16.65 | €6.22 7.18 USD | ||
BioNTech SE
BNTXN.MX
MX
|
MX$1,590.00 94.15 USD |
0
|
MX$402.09B 23.81B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$402.09B 23.81B USD | 0 | -MX$101.12 -5.9 USD | ||
Genmab A/S
0MGB.IL
GB
|
DKK 1,819.50 266.78 USD |
-2.45
|
DKK 145.71B 21.36B USD | DKK 24.00 3.52 USD | DKK 0.00 0 USD | DKK 0.00 0 USD | DKK 145.71B 21.36B USD | 25.71 | DKK 70.77 10.38 USD | ||
Incyte Corporation
INCY.MX
MX
|
MX$1,676.03 99.24 USD |
0
|
MX$334.84B 19.83B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$334.84B 19.83B USD | 13.51 | MX$124.03 7.34 USD | ||
WuXi Biologics (Cayman) Inc.
1FW2.F
DE
|
€4.18 4.83 USD |
0
|
€17.16B 19.81B USD | €2.50K 2.89K USD | €4.18 4.83 USD | €4.18 4.83 USD | €17.16B 19.81B USD | 27.86 | €0.15 0.17 USD | ||
Innovent Biologics, Inc.
6IB.F
DE
|
€9.86 11.38 USD |
0
|
€17.09B 19.73B USD | €30.00 34.63 USD | €9.86 11.38 USD | €10.00 11.55 USD | €17.09B 19.73B USD | 164.25 | €0.06 0.07 USD | ||
WuXi Biologics (Cayman) Inc.
1FW1.F
DE
|
€8.25 9.52 USD |
0
|
€16.94B 19.55B USD | €134.00 154.68 USD | €8.25 9.52 USD | €8.25 9.52 USD | €16.94B 19.55B USD | 27.49 | €0.30 0.35 USD | ||
WuXi Biologics (Cayman)
WXIBF
US
|
$4.40 — |
-5.98
|
$18.07B — | $250.00 — | $4.40 — | $4.40 — | $18.07B — | 25.88 | $0.17 — | ||
Genmab A/S
GE91.F
DE
|
€24.80 28.63 USD |
0
|
€15.23B 17.58B USD | €600.00 692.6 USD | €24.80 28.63 USD | €24.80 28.63 USD | €15.23B 17.58B USD | 21.37 | €1.16 1.34 USD | ||
GENMAB AS N
GE9.DE
DE
|
€246.20 284.2 USD |
-1.52
|
€15.12B 17.45B USD | €77.00 88.88 USD | €246.20 284.2 USD | €246.20 284.2 USD | €15.12B 17.45B USD | 21.31 | €11.55 13.33 USD | ||
Genmab A/S
GNMSF
US
|
$282.16 — |
+2.6
|
$17.32B — | $140.00 — | $275.00 — | $275.00 — | $17.32B — | 21.45 | $13.15 — | ||
Jazz Pharmaceuticals plc
J7Z.F
DE
|
€212.30 245.07 USD |
0
|
€13.34B 15.39B USD | €50.00 57.72 USD | €211.50 244.14 USD | €214.20 247.26 USD | €13.34B 15.39B USD | 2358.88 | €0.09 0.1 USD | ||
BridgeBio Pharma, Inc.
2CL.F
DE
|
€68.07 78.58 USD |
0
|
€13.33B 15.39B USD | €70.00 80.8 USD | €66.50 76.76 USD | €68.07 78.58 USD | €13.33B 15.39B USD | 0 | -€3.29 -3.7 USD | ||
Ascendis Pharma A/S
A71.F
DE
|
€206.00 237.79 USD |
0
|
€12.65B 14.6B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €12.65B 14.6B USD | 0 | €0.00 0 USD | ||
Exelixis, Inc.
EX9.F
DE
|
€48.94 56.49 USD |
0
|
€12.30B 14.2B USD | €1.59K 1.83K USD | €48.52 56.01 USD | €49.12 56.7 USD | €12.30B 14.2B USD | 18.46 | €2.65 3.06 USD | ||
Verona Pharma plc
I9SA.F
DE
|
€90.20 104.12 USD |
0
|
€12.13B 14.01B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €12.13B 14.01B USD | 0 | €0.00 0 USD | ||
Sino Biopharmaceutical Limited
SBMFF
US
|
$0.78 — |
-6.28
|
$13.83B — | $2.00K — | $0.78 — | $0.78 — | $13.83B — | 38.89 | $0.02 — | ||
ALTEOGEN Inc.
196170.KQ
KR
|
₩335,000 252.87 USD |
+1.21
|
₩18T 13.53B USD | ₩318K 239.69 USD | ₩326,000 246.08 USD | ₩346,000 261.17 USD | ₩18T 13.53B USD | 0 | ₩0 0 USD | ||
Axsome Therapeutics, Inc.
19X.F
DE
|
€216.70 250.14 USD |
0
|
€11.15B 12.87B USD | €14.00 16.16 USD | €216.70 250.14 USD | €216.70 250.14 USD | €11.15B 12.87B USD | 0 | -€3.27 -3.7 USD | ||
Madrigal Pharmaceuticals, Inc.
YDO1.F
DE
|
€460.30 531.34 USD |
0
|
€10.61B 12.25B USD | €16.00 18.47 USD | €456.50 526.95 USD | €464.20 535.84 USD | €10.61B 12.25B USD | 0 | -€11.84 -13.6 USD | ||
Arrowhead Pharmaceuticals, Inc.
HDP1.F
DE
|
€75.08 86.67 USD |
0
|
€10.58B 12.21B USD | €115.00 132.75 USD | €72.98 84.24 USD | €76.40 88.19 USD | €10.58B 12.21B USD | 0 | -€1.99 -2.2 USD | ||
Akeso, Inc.
4RY.F
DE
|
€11.31 13.05 USD |
0
|
€10.41B 12.02B USD | €709.00 818.42 USD | €11.28 13.02 USD | €11.31 13.05 USD | €10.41B 12.02B USD | 0 | -€0.16 -0.1 USD | ||
ABIVAX Société Anonyme
2X1.F
DE
|
€127.90 147.64 USD |
0
|
€10.21B 11.78B USD | €30.00 34.63 USD | €127.90 147.64 USD | €131.50 151.79 USD | €10.21B 11.78B USD | 0 | -€4.61 -5.3 USD | ||
Cytokinetics, Incorporated
KK3A.F
DE
|
€74.84 86.39 USD |
0
|
€10.16B 11.73B USD | €37.00 42.71 USD | €74.18 85.63 USD | €74.84 86.39 USD | €10.16B 11.73B USD | 0 | -€6.01 -6.9 USD | ||
BioMarin Pharmaceutical Inc.
BM8.F
DE
|
€51.96 59.98 USD |
0
|
€10.04B 11.59B USD | €100.00 115.43 USD | €51.96 59.98 USD | €51.96 59.98 USD | €10.04B 11.59B USD | 42.59 | €1.22 1.41 USD | ||
Bio-Techne Corporation
T1CH34.SA
BR
|
R$12.21 2.47 USD |
-1.37
|
R$57.07B 11.57B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$57.07B 11.57B USD | 101.75 | R$0.12 0.02 USD | ||
Financière de Tubize SA
FTD.F
DE
|
€223.00 257.42 USD |
-1.59
|
€9.93B 11.46B USD | €100.00 115.43 USD | €223.00 257.42 USD | €223.00 257.42 USD | €9.93B 11.46B USD | 107.21 | €2.08 2.4 USD | ||
BioMarin Pharmaceutical Inc.
BMRN.VI
AT
|
€51.18 59.08 USD |
-1.84
|
€9.89B 11.42B USD | €27.00 31.17 USD | €51.18 59.08 USD | €52.12 60.16 USD | €9.89B 11.42B USD | 41.95 | €1.22 1.41 USD | ||
Sino Biopharmaceutical
SBHMY
US
|
$12.68 — |
0
|
$11.27B — | $128.00 — | $12.68 — | $12.68 — | $11.27B — | 33.36 | $0.38 — | ||
Sino Biopharmaceutical Limited
SMZ1.F
DE
|
€0.55 0.63 USD |
+3.51
|
€9.75B 11.25B USD | €2.50K 2.89K USD | €0.55 0.63 USD | €0.55 0.63 USD | €9.75B 11.25B USD | 27.42 | €0.02 0.02 USD | ||
Ionis Pharmaceuticals, Inc.
IONS.MX
MX
|
MX$1,150.00 68.09 USD |
0
|
MX$190.05B 11.25B USD | MX$0.00 0 USD | MX$1,150.00 68.09 USD | MX$1,150.00 68.09 USD | MX$190.05B 11.25B USD | 0 | -MX$28.98 -1.7 USD | ||
Financière de Tubize SA
FTD.SG
DE
|
€217.40 250.95 USD |
-0.37
|
€9.68B 11.17B USD | €0.00 0 USD | €217.40 250.95 USD | €217.40 250.95 USD | €9.68B 11.17B USD | 103.52 | €2.10 2.42 USD | ||
Krystal Biotech, Inc.
4KB.F
DE
|
€325.90 376.2 USD |
0
|
€9.61B 11.09B USD | €18.00 20.78 USD | €325.90 376.2 USD | €325.90 376.2 USD | €9.61B 11.09B USD | 49.83 | €6.54 7.55 USD | ||
Bio-Techne Corporation
TE1.F
DE
|
€61.40 70.88 USD |
-0.26
|
€9.57B 11.04B USD | €13.00 15.01 USD | €61.40 70.88 USD | €61.76 71.29 USD | €9.57B 11.04B USD | 99.03 | €0.62 0.72 USD | ||
Krystal Biotech, Inc.
4KB.SG
DE
|
€324.50 374.58 USD |
-0.67
|
€9.57B 11.04B USD | €0.00 0 USD | €324.50 374.58 USD | €324.50 374.58 USD | €9.57B 11.04B USD | 49.46 | €6.56 7.57 USD | ||
BioMarin Pharmaceutical Inc.
B1MR34.SA
BR
|
R$140.85 28.55 USD |
0
|
R$54.45B 11.04B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$54.45B 11.04B USD | 39.01 | R$3.61 0.73 USD | ||
BioMarin Pharmaceutical Inc.
BMRN.MX
MX
|
MX$959.00 56.78 USD |
0
|
MX$185.36B 10.98B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$185.36B 10.98B USD | 39.36 | MX$24.36 1.44 USD | ||
Bio-Techne Corporation
TECH.MX
MX
|
MX$1,064.35 63.02 USD |
0
|
MX$169.12B 10.01B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$169.12B 10.01B USD | 0 | MX$0.00 0 USD | ||
Corcept Therapeutics Incorporated
HTD.F
DE
|
€80.28 92.67 USD |
0
|
€8.62B 9.95B USD | €8.00 9.23 USD | €77.34 89.28 USD | €80.28 92.67 USD | €8.62B 9.95B USD | 258.96 | €0.31 0.36 USD | ||
Halozyme Therapeutics, Inc.
RV7.F
DE
|
€69.28 79.97 USD |
0
|
€8.22B 9.49B USD | €70.00 80.8 USD | €68.04 78.54 USD | €69.28 79.97 USD | €8.22B 9.49B USD | 27.71 | €2.50 2.89 USD | ||
ImmunityBio, Inc.
26CA.F
DE
|
€7.75 8.95 USD |
0
|
€8.12B 9.37B USD | €1.36K 1.57K USD | €7.62 8.8 USD | €8.20 9.47 USD | €8.12B 9.37B USD | 0 | -€0.75 -0.8 USD | ||
Halozyme Therapeutics, Inc.
HALO.MX
MX
|
MX$1,327.00 78.57 USD |
0
|
MX$157.40B 9.32B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$157.40B 9.32B USD | 26.59 | MX$49.90 2.95 USD | ||
Jazz Pharmaceuticals plc
JAZZN.MX
MX
|
MX$2,500.00 148.03 USD |
0
|
MX$157.04B 9.3B USD | MX$0.00 0 USD | MX$2,500.00 148.03 USD | MX$2,500.00 148.03 USD | MX$157.04B 9.3B USD | 0 | -MX$106.00 -6.2 USD | ||
Vaxcyte, Inc.
5VA.MU
DE
|
€51.00 58.87 USD |
+0.99
|
€7.36B 8.5B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €7.36B 8.5B USD | 0 | -€6.05 -6.9 USD | ||
ALK-Abelló A/S
4AJ0.F
DE
|
€32.56 37.59 USD |
-0.67
|
€7.21B 8.33B USD | €333.00 384.39 USD | €32.56 37.59 USD | €32.56 37.59 USD | €7.21B 8.33B USD | 42.28 | €0.77 0.89 USD | ||
Biocon Limited
BIOCON.BO
IN
|
₹419.50 5.08 USD |
-1.21
|
₹683.07B 8.26B USD | ₹32.74K 396.1 USD | ₹416.95 5.04 USD | ₹426.00 5.15 USD | ₹683.07B 8.26B USD | 149.28 | ₹2.81 0.03 USD | ||
TG Therapeutics, Inc.
NKB2.F
DE
|
€46.40 53.56 USD |
0
|
€7.10B 8.2B USD | €464.00 535.61 USD | €46.40 53.56 USD | €46.40 53.56 USD | €7.10B 8.2B USD | 18.48 | €2.51 2.9 USD | ||
Vaxcyte, Inc.
5VA.F
DE
|
€48.80 56.33 USD |
0
|
€7.05B 8.13B USD | €6.00 6.93 USD | €48.80 56.33 USD | €48.80 56.33 USD | €7.05B 8.13B USD | 0 | -€6.05 -6.9 USD | ||
Mirum Pharmaceuticals, Inc.
08D.F
DE
|
€107.10 123.63 USD |
-0.23
|
€6.53B 7.54B USD | €15.00 17.32 USD | €107.10 123.63 USD | €108.05 124.73 USD | €6.53B 7.54B USD | 0 | -€11.93 -13.7 USD | ||
Rhythm Pharmaceuticals, Inc.
1RV.F
DE
|
€94.00 108.51 USD |
0
|
€6.45B 7.44B USD | €49.00 56.56 USD | €94.00 108.51 USD | €99.00 114.28 USD | €6.45B 7.44B USD | 0 | -€2.75 -3.1 USD | ||
Merus N.V.
2GH.F
DE
|
€79.00 91.19 USD |
0
|
€6.11B 7.05B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €6.11B 7.05B USD | 0 | €0.00 0 USD | ||
Cidara Therapeutics
CDTX
US
|
$221.38 — |
0
|
$6.96B — | $0.00 — | $0.00 — | $0.00 — | $6.96B — | 0 | $0.00 — | ||
ALK-Abelló A/S
AKBLF
US
|
$31.35 — |
-22.88
|
$6.95B — | $105.00 — | $31.35 — | $31.35 — | $6.95B — | 35.62 | $0.88 — | ||
Merus
MRUS
US
|
$90.00 — |
0
|
$6.83B — | $0.00 — | $0.00 — | $0.00 — | $6.83B — | 0 | $0.00 — | ||
RemeGen Co., Ltd.
REG.F
DE
|
€9.56 11.03 USD |
0
|
€5.75B 6.64B USD | €50.00 57.72 USD | €9.56 11.03 USD | €9.56 11.03 USD | €5.75B 6.64B USD | 56.21 | €0.17 0.2 USD | ||
Scholar Rock Holding Corporation
2QK.F
DE
|
€47.68 55.04 USD |
0
|
€5.71B 6.6B USD | €30.00 34.63 USD | €47.68 55.04 USD | €47.68 55.04 USD | €5.71B 6.6B USD | 0 | -€3.03 -3.4 USD | ||
ABIVAX Société Anonyme
AAVXF
US
|
$80.03 — |
0
|
$6.39B — | $500.00 — | $80.03 — | $90.45 — | $6.39B — | 0 | -$5.25 — | ||
CRISPR Therapeutics AG
CRSPN.MX
MX
|
MX$1,090.00 64.54 USD |
+3.61
|
MX$107.35B 6.36B USD | MX$1.54K 91.13 USD | MX$1,070.00 63.36 USD | MX$1,090.00 64.54 USD | MX$107.35B 6.36B USD | 0 | -MX$108.04 -6.3 USD | ||
Ligand Pharmaceuticals Incorporated
LGDN.F
DE
|
€272.00 313.98 USD |
-2.86
|
€5.45B 6.29B USD | €20.00 23.09 USD | €272.00 313.98 USD | €278.00 320.9 USD | €5.45B 6.29B USD | 40.29 | €6.75 7.79 USD | ||
Centessa Pharmaceuticals plc
260.F
DE
|
€34.60 39.94 USD |
0
|
€5.35B 6.18B USD | €270.00 311.67 USD | €34.20 39.48 USD | €34.60 39.94 USD | €5.35B 6.18B USD | 0 | -€1.56 -1.8 USD | ||
3SBio Inc.
83B.F
DE
|
€2.13 2.45 USD |
0
|
€5.31B 6.13B USD | €1.05K 1.21K USD | €2.10 2.42 USD | €2.22 2.56 USD | €5.31B 6.13B USD | 4.83 | €0.44 0.51 USD | ||
Xenon Pharmaceuticals Inc.
XP0.F
DE
|
€53.00 61.18 USD |
0
|
€5.12B 5.91B USD | €43.00 49.64 USD | €53.00 61.18 USD | €53.00 61.18 USD | €5.12B 5.91B USD | 0 | -€4.12 -4.7 USD | ||
Legend Biotech Corporation
9LB.F
DE
|
€24.40 28.17 USD |
0
|
€4.72B 5.45B USD | €40.00 46.17 USD | €24.20 27.93 USD | €26.20 30.24 USD | €4.72B 5.45B USD | 0 | -€1.21 -1.3 USD | ||
Asymchem Laboratories (Tianjin) Co., Ltd.
7K90.F
DE
|
€12.40 14.31 USD |
0
|
€4.47B 5.16B USD | €4.00 4.62 USD | €12.40 14.31 USD | €12.40 14.31 USD | €4.47B 5.16B USD | 30.99 | €0.40 0.46 USD | ||
HLB Co., Ltd.
028300.KQ
KR
|
₩51,100 38.57 USD |
+4.82
|
₩7T 5.13B USD | ₩813K 613.86 USD | ₩47,650 35.97 USD | ₩51,300 38.72 USD | ₩7T 5.13B USD | 0 | ₩0 0 USD | ||
Apellis Pharmaceuticals Inc
1JK.F
DE
|
€34.11 39.37 USD |
0
|
€4.37B 5.04B USD | €10.00 11.54 USD | €34.11 39.37 USD | €34.11 39.37 USD | €4.37B 5.04B USD | 37.48 | €0.91 1.05 USD | ||
SK Biopharmaceuticals Co., Ltd.
326030.KS
KR
|
₩84,300 63.63 USD |
+0.36
|
₩7T 4.98B USD | ₩80K 60.16 USD | ₩82,700 62.42 USD | ₩85,600 64.61 USD | ₩7T 4.98B USD | 0 | ₩0 0 USD | ||
Amicus Therapeutics
FOLD
US
|
$14.49 — |
0
|
$4.55B — | $0.00 — | $0.00 — | $0.00 — | $4.55B — | 0 | $0.00 — | ||
Crinetics Pharmaceuticals, Inc.
6Z4.F
DE
|
€37.28 43.03 USD |
0
|
€3.93B 4.54B USD | €60.00 69.26 USD | €36.40 42.02 USD | €37.28 43.03 USD | €3.93B 4.54B USD | 0 | -€4.51 -5.2 USD | ||
Akero Therapeutics
AKRO
US
|
$54.65 — |
0
|
$4.50B — | $0.00 — | $0.00 — | $0.00 — | $4.50B — | 0 | $0.00 — | ||
ACADIA Pharmaceuticals Inc.
DR6.F
DE
|
€22.64 26.13 USD |
0
|
€3.88B 4.48B USD | €20.00 23.09 USD | €22.64 26.13 USD | €22.64 26.13 USD | €3.88B 4.48B USD | 11.67 | €1.94 2.24 USD | ||
Akero Therapeutics, Inc.
0K4.F
DE
|
€46.53 53.71 USD |
0
|
€3.85B 4.44B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €3.85B 4.44B USD | 0 | €0.00 0 USD | ||
ALK-Abelló A/S
0OIR.IL
GB
|
DKK 149.45 21.91 USD |
0
|
DKK 30.00B 4.4B USD | DKK 839.00 123.02 USD | DKK 0.00 0 USD | DKK 0.00 0 USD | DKK 30.00B 4.4B USD | 92.82 | DKK 1.61 0.24 USD | ||
Viking Therapeutics, Inc.
1VT.F
DE
|
€32.45 37.46 USD |
0
|
€3.77B 4.35B USD | €50.00 57.72 USD | €32.45 37.46 USD | €32.45 37.46 USD | €3.77B 4.35B USD | 0 | -€3.64 -4.2 USD | ||
Agios Pharmaceuticals, Inc.
AGIO.MX
MX
|
MX$1,222.00 72.36 USD |
0
|
MX$72.67B 4.3B USD | MX$0.00 0 USD | MX$1,222.00 72.36 USD | MX$1,222.00 72.36 USD | MX$72.67B 4.3B USD | 5.16 | MX$236.58 14.01 USD | ||
Denali Therapeutics Inc.
4DN.MU
DE
|
€22.95 26.49 USD |
-0.13
|
€3.64B 4.2B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €3.64B 4.2B USD | 0 | -€2.53 -2.9 USD | ||
|
Favori hisse senedi yok.
Henüz favori bir hisse senediniz yok, lütfen burada görmek için favorilere ekleyin |
|||||||||||


